Patents by Inventor Christopher P. Laudeman

Christopher P. Laudeman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120295915
    Abstract: Disclosed are compounds having Formula (I), wherein R1, R2, R3, R4, Ra, Rb, X, Y, m, and n are defined herein and methods of using the same.
    Type: Application
    Filed: November 22, 2010
    Publication date: November 22, 2012
    Inventors: Amita M. Chaudhari, Jason Hallman, Christopher P. Laudeman, David Lee Musso, Cynthia A. Parrish
  • Publication number: 20120277258
    Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
    Type: Application
    Filed: July 10, 2012
    Publication date: November 1, 2012
    Inventors: Amogh Boloor, Mui Cheung, Philip Anthony Harris, Kevin Hinkle, Christopher P. Laudeman, Jeffrey Alan Stafford, James Marvin Veal
  • Publication number: 20100240642
    Abstract: The present invention relates to certain indole derivatives that are modulators of PPAR?, to processes for their preparation, to pharmaceutical compositions containing them and to their use in medicine.
    Type: Application
    Filed: August 31, 2007
    Publication date: September 23, 2010
    Inventors: Jeffrey Alan Oplinger, Paul Kenneth Spearing, Millard Hurst Lambert, John A. Ray, Christopher P. Laudeman, Jerzy R. Szewczyk, Pierette Banker
  • Publication number: 20090069302
    Abstract: The present invention relates generally to novel therapeutic compounds and AXOR 109 agonists, and processes for the manufacture and use of the same.
    Type: Application
    Filed: January 19, 2007
    Publication date: March 12, 2009
    Inventors: Jerzy Ryszard Szewczyk, Christopher P. Laudeman, Thomas Dock, Zibin Chen, Anderson Evans, Yue H. Li
  • Patent number: 5811241
    Abstract: The invention provides a method of synthesizing N-substituted 1,4-piperazines and N-substituted 1,4-piperazinediones. The invention also provides a method for synthesing combinatorial libraries of piperazine derivatives which can be assayed for biological activity in pre-specified ligand binding or enzymatic activity screens.
    Type: Grant
    Filed: September 13, 1995
    Date of Patent: September 22, 1998
    Assignee: Cortech, Inc.
    Inventors: Val S. Goodfellow, Donald A. McLeod, James Ivan Gerrity, Christopher P. Laudeman, Michael R. Burkard